<SEC-DOCUMENT>0001193125-25-338322.txt : 20251231
<SEC-HEADER>0001193125-25-338322.hdr.sgml : 20251231
<ACCEPTANCE-DATETIME>20251231161430
ACCESSION NUMBER:		0001193125-25-338322
CONFORMED SUBMISSION TYPE:	4
PUBLIC DOCUMENT COUNT:		1
CONFORMED PERIOD OF REPORT:	20251229
FILED AS OF DATE:		20251231
DATE AS OF CHANGE:		20251231

REPORTING-OWNER:	

	OWNER DATA:	
		COMPANY CONFORMED NAME:			Webster Brian Daniel
		CENTRAL INDEX KEY:			0001877188
		ORGANIZATION NAME:           	

	FILING VALUES:
		FORM TYPE:		4
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-42549
		FILM NUMBER:		251617608

	MAIL ADDRESS:	
		STREET 1:		3933 LAKE WASHINGTON BLVD NE
		STREET 2:		SUITE 200
		CITY:			KIRKLAND
		STATE:			WA
		ZIP:			98033

ISSUER:		

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			KESTRA MEDICAL TECHNOLOGIES, LTD.
		CENTRAL INDEX KEY:			0001877184
		STANDARD INDUSTRIAL CLASSIFICATION:	SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
		ORGANIZATION NAME:           	08 Industrial Applications and Services
		EIN:				000000000
		STATE OF INCORPORATION:			D0
		FISCAL YEAR END:			0430

	BUSINESS ADDRESS:	
		STREET 1:		3933 LAKE WASHINGTON BLVD NE
		STREET 2:		SUITE 200
		CITY:			KIRKLAND
		STATE:			WA
		ZIP:			98033
		BUSINESS PHONE:		(425) 279-8002

	MAIL ADDRESS:	
		STREET 1:		3933 LAKE WASHINGTON BLVD NE
		STREET 2:		SUITE 200
		CITY:			KIRKLAND
		STATE:			WA
		ZIP:			98033
</SEC-HEADER>
<DOCUMENT>
<TYPE>4
<SEQUENCE>1
<FILENAME>ownership.xml
<DESCRIPTION>4
<TEXT>
<XML>
<?xml version="1.0"?>
<ownershipDocument>

    <schemaVersion>X0508</schemaVersion>

    <documentType>4</documentType>

    <periodOfReport>2025-12-29</periodOfReport>

    <issuer>
        <issuerCik>0001877184</issuerCik>
        <issuerName>KESTRA MEDICAL TECHNOLOGIES, LTD.</issuerName>
        <issuerTradingSymbol>KMTS</issuerTradingSymbol>
    </issuer>

    <reportingOwner>
        <reportingOwnerId>
            <rptOwnerCik>0001877188</rptOwnerCik>
            <rptOwnerName>Webster Brian Daniel</rptOwnerName>
        </reportingOwnerId>
        <reportingOwnerAddress>
            <rptOwnerStreet1>C/O KESTRA MEDICAL TECHNOLOGIES, LTD.</rptOwnerStreet1>
            <rptOwnerStreet2>3933 LAKE WASHINGTON BLVD NE, SUITE 200</rptOwnerStreet2>
            <rptOwnerCity>KIRKLAND</rptOwnerCity>
            <rptOwnerState>WA</rptOwnerState>
            <rptOwnerZipCode>98033</rptOwnerZipCode>
            <rptOwnerStateDescription></rptOwnerStateDescription>
        </reportingOwnerAddress>
        <reportingOwnerRelationship>
            <isDirector>true</isDirector>
            <isOfficer>true</isOfficer>
            <isTenPercentOwner>false</isTenPercentOwner>
            <isOther>false</isOther>
            <officerTitle>See Remarks</officerTitle>
        </reportingOwnerRelationship>
    </reportingOwner>

    <aff10b5One>true</aff10b5One>

    <nonDerivativeTable>
        <nonDerivativeTransaction>
            <securityTitle>
                <value>Common Shares</value>
            </securityTitle>
            <transactionDate>
                <value>2025-12-29</value>
            </transactionDate>
            <transactionCoding>
                <transactionFormType>4</transactionFormType>
                <transactionCode>S</transactionCode>
                <equitySwapInvolved>false</equitySwapInvolved>
                <footnoteId id="F1"/>
            </transactionCoding>
            <transactionAmounts>
                <transactionShares>
                    <value>15000</value>
                </transactionShares>
                <transactionPricePerShare>
                    <value>26.5898</value>
                    <footnoteId id="F2"/>
                </transactionPricePerShare>
                <transactionAcquiredDisposedCode>
                    <value>D</value>
                </transactionAcquiredDisposedCode>
            </transactionAmounts>
            <postTransactionAmounts>
                <sharesOwnedFollowingTransaction>
                    <value>409786</value>
                    <footnoteId id="F3"/>
                </sharesOwnedFollowingTransaction>
            </postTransactionAmounts>
            <ownershipNature>
                <directOrIndirectOwnership>
                    <value>D</value>
                </directOrIndirectOwnership>
            </ownershipNature>
        </nonDerivativeTransaction>
    </nonDerivativeTable>

    <footnotes>
        <footnote id="F1">The reported transaction occurred pursuant to a Rule 10b5-1 trading plan adopted on September 29, 2025.</footnote>
        <footnote id="F2">The price in Column 4 is a weighted average price. The prices at which the reported securities were sold ranged from $26.390 to $26.9504. Upon request, the reporting person will provide to the Issuer, any security holder of the Issuer, or the SEC staff, information regarding the number of shares at each price within the range.</footnote>
        <footnote id="F3">Includes 27,209 Common Shares received from West Affum Holdings, L.P. in a pro rata distribution exempt pursuant to Rule 16a-9.</footnote>
    </footnotes>

    <remarks>President and Chief Executive Officer</remarks>

    <ownerSignature>
        <signatureName>/s/ Brian Daniel Webster</signatureName>
        <signatureDate>2025-12-31</signatureDate>
    </ownerSignature>
</ownershipDocument>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
